title: Prolongation of concordant xenograft survival by a newly developed drug, FTY720.
authors.affiliation: Second Department of Surgery, Kyoto Prefectural University of Medicine, Japan.
authors.forename: I
authors.initials: I
authors.lastname: Fujiwara
authors.forename: H
authors.initials: H
authors.lastname: Nakajima
authors.forename: T
authors.initials: T
authors.lastname: Matsuda
authors.forename: N
authors.initials: N
authors.lastname: Mizuta
authors.forename: H
authors.initials: H
authors.lastname: Yamagishi
authors.forename: T
authors.initials: T
authors.lastname: Oka
mesh_terms: D000818:Animals; D000910:Antibodies, Heterophile / Q000097:blood; D003131:Combined Modality Therapy; D006224:Cricetinae; D000068876:Fingolimod Hydrochloride; D006085:Graft Survival / Q000187:drug effects* / Q000276:immunology; D006146:Guanidines / Q000627:therapeutic use; D016027:Heart Transplantation / Q000276:immunology* / Q000473:pathology; D007165:Immunosuppression Therapy / Q000379:methods; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007959:Lymphocyte Culture Test, Mixed; D011409:Propylene Glycols / Q000627:therapeutic use*; D051381:Rats; D011917:Rats, Inbred Lew; D013110:Sphingosine / Q000031:analogs & derivatives; D013154:Spleen / Q000276:immunology; D013156:Splenectomy; D014183:Transplantation, Heterologous / Q000276:immunology* / Q000473:pathology
chemical_list: D000910:Antibodies, Heterophile; D006146:Guanidines; D007166:Immunosuppressive Agents; D011409:Propylene Glycols; D000068876:Fingolimod Hydrochloride; D013110:Sphingosine; C037258:gusperimus